Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function Łukasz MielczarekAnna BrodziakAnna M. Czarnecka Review Article Open access 25 March 2021 Pages: 723 - 742
Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology Stephanie N. LiuChunze Li Review Article Open access 01 April 2021 Pages: 743 - 765
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers Kazuo KobayashiErika SugiyamaKensei Yamaguchi Original Article 26 February 2021 Pages: 767 - 777
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers Wen Wee MaMojun ZhuAntonio Jimeno Original Article 26 February 2021 Pages: 779 - 788
Clinical significance of circulating tumor cells in the response to trastuzumab for HER2-negative metastatic gastric cancer Daisuke MatsushitaYoshikazu UenosonoShoji Natsugoe Original Article 28 February 2021 Pages: 789 - 797
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma Ahmad ShabsighNir KleinmannSeth P. Lerner Original Article Open access 07 March 2021 Pages: 799 - 805
A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcoma Elizabeth FoxChristine BuschFrank Balis Original Article 07 March 2021 Pages: 807 - 815
Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens Sarah M. KashanianNoa G. HoltzmanAshkan Emadi Original Article 07 March 2021 Pages: 817 - 826
Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition Narges K. GortanyGhodratollah PanahiMahmoud Ghazi-Khansari Original Article 10 March 2021 Pages: 827 - 842
Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients Eneida Turiján-EspinozaVíctor Manuel Ruíz-RodríguezDiana Patricia Portales-Pérez Original Article 19 March 2021 Pages: 843 - 853
Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours Marit A. C. VermuntLisa T. van der HeijdenJos H. Beijnen Original Article 20 March 2021 Pages: 855 - 869
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases Hiroaki IkesueKohei DoiTohru Hashida Short Communication Open access 31 March 2021 Pages: 871 - 877
Correction to: Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega‑3 polyunsaturated fatty acid eicosapentaenoic acid Milene VolpatoNicola IngramMark A Hull Correction 17 November 2020 Pages: 879 - 880